220
Participants
Start Date
May 31, 2004
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
zoledronic acid
University of Pittsburgh, Pittsburgh
Radiant Research, Wyomissing
Florida Medical Research Institute, Gainsville
Radiant Research, Stuart
University of Kansas School of Medicine/ Division of Endocrinology, Kansas City
Creighton University Osteoporosis Research Center, Omaha
Arthritis Center of Nebraska, Lincoln
Colorado Center for Bone Research, Lakewood
The Permanente Medical Group, Santa Rosa
Oregon Osteoporosis Center, Portland
Puget Sound Osteoporosis Center, Seattle
Clinical Pharmacology Study Group, Worcester
Novartis, Nuremberg
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY